Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science.

Studies include:
Structural Heart Interventions   
00:53: Chimney stenting vs BASILICA to prevent TAVR-related coronary obstruction 
2:18: Outcomes of repeat TAVR with balloon-expandable valves
4:18: FAST-TAVI II: Evaluation of Length of Stay After TF-TAVI

Coronary Interventions
6:55: REFORM: Randomised trial of biolimus DEB for in-stent restenosis
8:20: TRANSFORM I: Sirolimus-coated balloon vs. paclitaxel-coated balloon in de novo small vessel disease

Tricuspid
10:43: MITRAL: Outcomes of TMVR vs medical therapy for secondary mitral regurgitation
12:09: DRAGONFLY-DMR: Transcatheter repair by DragonFly device in mitral regurgitation
13:53: CHOICE-MI: Choice of optImal transcatheter treatment for mitral insufficiency registry

Long-term data from PCI trials
16:27: ABSORB IV: Blinded outcomes and angina assessment of coronary bioresorbable scaffolds
18:39: FAME 3: FFR-guided PCI vs CABG - Three-year follow-up 
20:06: DEFINE-FLAIR: Functional lesion assessment of intermediate stenosis to guide revascularization

Cardiogenic shock:
20:50: EUROSHOCK: Extracorporeal membrane oxygenation vs standard care in cardiogenic shock

Bifurcation data
23:15: EBC TWO: Provisional vs. culotte for coronary bifurcations
23:52: EBC MAIN: The European Bifurcation Club left main coronary stent study

Renal denervation
26:10: SMART: Pivotal trial of targeted renal denervation to treat hypertension